about
Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expressionGhrelin alone or co-administered with GHRH or CRH increases non-REM sleep and decreases REM sleep in young malesThe neuronal transporter gene SLC6A15 confers risk to major depressionPolymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatmentGenetic relationship between five psychiatric disorders estimated from genome-wide SNPsLithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patientsAssociation of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humansEvidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosisA mega-analysis of genome-wide association studies for major depressive disorderDexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patientsAnle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiologyHigh-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response.Glyoxalase-I mRNA expression and CCK-4 induced panic attacks.Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects.Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls.Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels.Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders.Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder.Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder.Gender-specific association of galanin polymorphisms with HPA-axis dysregulation, symptom severity, and antidepressant treatment response.Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome.Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controlsHypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice.Analyzing pathways from childhood maltreatment to internalizing symptoms and disorders in children and adolescents (AMIS): a study protocol.Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depression.A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depressionGenetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders.ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response.Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients.Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks.Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans.Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study.The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases.Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
P50
Q24305207-3462BF49-7CCF-4E60-AF18-863ABA680ED9Q24308834-03E33692-98A1-49F1-B955-9AF1FF128630Q24617186-A388EF15-1765-4458-99EC-F06C5218D44FQ28295248-F5CD81B3-6889-41B8-BCD2-F97AB55609C3Q28296286-77040DE6-11B1-48FB-AEC6-42B9DF02F0F8Q28478124-41A3CBC6-6E88-4F8F-9A42-EF624FA58E77Q28544844-F5BB0BC7-7D22-4CA3-A38F-0DAE321A9DA5Q28943369-DA3FAFB8-5DB2-4E1B-882D-E13A25153385Q29417093-25896A16-D49F-4603-979F-C6623AE1BA56Q30455078-865FF6E2-CBD9-41AF-B90C-A2C4469A3F14Q30540027-06FC89C6-2D24-499E-945D-CCA4929FC970Q30816299-02829DF3-6505-4082-99EC-EA9C42E13C97Q31043451-FA290FB9-3817-416C-82B2-977D0CA8030DQ31099140-1B8C99D9-11DA-4974-99B8-E08E097A059FQ33602578-A9A09866-6958-484C-8CD7-61F6F4F9EE9EQ34270532-04CDF445-6C92-4735-8164-FBDADFAD6EC7Q34390429-CAC1FF72-2E19-4086-9321-2011D871BDC9Q34459775-E968C278-4178-4E87-A101-9BE064EC5EF5Q34596363-3132FB57-E189-48D3-A960-1450C9ECDC8CQ34620087-315D31A2-8C92-436A-ADCD-A94DAA666240Q34638119-C3A9E771-012A-4608-A9F1-57C96EB4E939Q34661003-8B1A86C2-C8D4-4CC6-916D-FB860B8FD710Q34721859-5AD59A70-5739-477A-B04D-313A96CA13BCQ34740072-ED2F54AB-6749-4615-97F9-DE8AB73DACCBQ34764142-D20EFF69-624E-471C-91D4-3388350945C4Q35178985-FDDA491A-ED61-467F-AFC0-030B6F30E2D1Q35644937-28FC8AAD-10A3-4AA3-88BA-5AFE8AB145B5Q35658628-6249788C-CD13-4F7D-8C90-9CF241BC3968Q35683252-5FA6ADA4-515B-4CE6-A42F-62FAEC653EF0Q35737324-10E02DE9-2047-4A52-BB4F-6499134DEFD3Q35814969-9BBBD0FC-12D8-4683-AABB-E045ED8EB7B6Q36510891-CEE78BA3-3663-4322-B368-A90FAF11B60DQ36965978-D81C586F-3539-469D-BCDA-78336603AE2AQ37301283-A158F93C-9D32-4D13-950C-A5E1C961C6C5Q37330439-F8AE29A8-1CB4-4098-B036-6B19D86DC315Q37376809-D797A0B3-140A-4E55-82A3-97D9AC73C8FFQ37914225-55EBBD5C-55AF-4582-9E0D-776BB5A984A1Q38111328-31221C7A-4956-4944-A831-EE3A641C04C4Q38453405-BCAA310F-B6BC-4F4C-AB76-250E04E05D16Q38476657-8FDEFA75-314A-457F-86BB-A8795F177B4B
P50
description
onderzoeker
@nl
name
Manfred Uhr
@ast
Manfred Uhr
@en
Manfred Uhr
@es
Manfred Uhr
@nl
Manfred Uhr
@sl
type
label
Manfred Uhr
@ast
Manfred Uhr
@en
Manfred Uhr
@es
Manfred Uhr
@nl
Manfred Uhr
@sl
prefLabel
Manfred Uhr
@ast
Manfred Uhr
@en
Manfred Uhr
@es
Manfred Uhr
@nl
Manfred Uhr
@sl